Aavrh.10Cucln2
Late Infantile Neuronal Ceroid Lipofuscinosis
Weill Medical College of Cornell Universitygene_therapyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Late Infantile Neuronal Ceroid Lipofuscinosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
Aavrh.10Cucln2 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →